ACTRN12612000503820
Completed
未知
In preterm infants born at <29 weeks gestation is an emulsion containing a higher amount of docosahexaenoic acid (DHA) more effective than an emulsion with no additional DHA in reducing the incidence of bronchopulmonary dysplasia at 36 weeks post menstrual age?
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Preterm infants
- Sponsor
- South Australian Health and Medical Research Institute
- Enrollment
- 1273
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Born at less than 29 weeks gestational age
- •Within 3 days of commencing enteral feeds
- •Has a legally acceptable representative capable of understanding the informed consent document and providing consent on the infant’s behalf
Exclusion Criteria
- •Infants who have a major congenital or chromosomal abnormality will be excluded from the study
- •Women providing breast milk who are taking supplements providing \>250 mg DHA per day and do not wish to stop taking supplements.
- •Infants participating in another fatty acid study.
- •Infants receiving intravenous lipid emulsions containing fish oil given as early lipid parenteral nutrition support.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Determining the docosahexaenoic acid dose to obtain plasma and erythrocyte phospholipid fatty acid profiles in preterm infants comparable to term infant profiles: a dose response pilot study.Preterm infantsDiet and Nutrition - Other diet and nutrition disordersReproductive Health and Childbirth - Complications of newbornACTRN12610000382077Women's and Children's Health Research Institute30
Completed
Not Applicable
Oropharyngeal airway for prevention of airway obstruction during positive pressure ventilation in preterm infants < 34 weeks gestation during neonatal resuscitation - a randomised trialeonatal ResuscitationPremature birthNeonatal ResuscitationReproductive Health and Childbirth - Complications of newbornRespiratory - Normal development and function of the respiratory systemACTRN12612000392864Royal Women's Hospital, Melbourne132
Completed
Not Applicable
Targeting of treatment of the patent ductus arteriosus using early echocardiographyACTRN12608000295347Martin Kluckow370
Not yet recruiting
Not Applicable
High Flow support versus Continuous Positive Airway Pressure (CPAP) support in non-acuterespiratory support for preterm infants from 30 weeks corrected gestatioACTRN12610000677000iverpool Hospital30
Terminated
Not Applicable
Improving child and parent outcomes after preterm birth using a web-based early intervention program (e-prem)ACTRN12614000906651Murdoch Childrens Research Institute103